GBp 29.0
(0.0%)
Breakdown | 2023 | 2022 |
---|---|---|
Operating Cash Flow | -133.85 Thousand | -517.64 Thousand |
Net Income | -705.03 Thousand | -617.7 Thousand |
Depreciation & Amortization | - | - |
Deferred income taxes | - | - |
Stock-based compensation | 318 Thousand | - |
Change in working capital | 318.42 Thousand | 59.43 Thousand |
Other non-cash items | 359.16 Thousand | 94.04 Thousand |
Investing Cash Flow | -310.94 Thousand | - |
Investments in PPE | -310.94 Thousand | - |
Acquisitions | - | - |
Investment purchases | - | - |
Sales/Maturities of investments | - | - |
Other Investing Activities | -374 Thousand | - |
Financing Cash Flow | 1.54 Million | 547.73 Thousand |
Debt repayment | - | - |
Dividends payments | - | - |
Common Stock Repurchased | - | - |
Common Stock Issuance | 1.54 Million | 547.73 Thousand |
Other Financing Activities | -296 Thousand | - |
Accounts receivables | -106.41 Thousand | -53.41 Thousand |
Accounts payables | - | - |
Inventory | - | - |
Other working capital | 424.84 Thousand | 112.85 Thousand |
Cash at beginning of period | 32.93 Thousand | 2841.00 |
Cash at end of period | 1.07 Million | 32.93 Thousand |
Capital Expenditure | -310.94 Thousand | - |
Effect of forex changes on cash | 2000.00 | - |
Net cash flow / Change in cash | 1.04 Million | 30.09 Thousand |
Free Cash Flow | -444.79 Thousand | -517.64 Thousand |
Breakdown | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY | 2021 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -455.7 Thousand | -705.03 Thousand | -619.53 Thousand | -71.53 Thousand | -617.7 Thousand | -26.41 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 318 Thousand | - | - | - | - |
Change in working capital | -67.03 Thousand | 318.42 Thousand | 54.25 Thousand | 256.32 Thousand | 59.43 Thousand | 68.98 Thousand |
Other non-cash items | 67.03 Thousand | 359.16 Thousand | 512.12 Thousand | -158.39 Thousand | 94.04 Thousand | 1.31 Million |
Investing Cash Flow | -110.93 Thousand | -310.94 Thousand | -107.41 Thousand | -195.86 Thousand | - | - |
Investments in PPE | -110.93 Thousand | -310.94 Thousand | -107.41 Thousand | -195.86 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | 1.54 Million | 1.51 Million | - | 547.73 Thousand | 10.27 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 1.54 Million | 1.51 Million | - | 547.73 Thousand | 10.27 Thousand |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | 74.22 Thousand | -106.41 Thousand | -244.3 Thousand | 140.51 Thousand | -53.41 Thousand | -1.31 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -141.25 Thousand | 424.84 Thousand | -115.81 Thousand | 115.81 Thousand | 112.85 Thousand | 1.37 Million |
Cash at beginning of period | 1.07 Million | 32.93 Thousand | 4987.95 | 33.94 Thousand | 2841.00 | - |
Cash at end of period | 595.38 Thousand | 1.07 Million | 1.07 Million | 4987.95 | 32.93 Thousand | 60.91 Thousand |
Capital Expenditure | -110.93 Thousand | -310.94 Thousand | -107.41 Thousand | -195.86 Thousand | - | - |
Effect of forex changes on cash | - | 2000.00 | - | - | - | - |
Net cash flow / Change in cash | -482.99 Thousand | 1.04 Million | 1.07 Million | -28.95 Thousand | 30.09 Thousand | 60.91 Thousand |
Free Cash Flow | -492.41 Thousand | -444.79 Thousand | -404.88 Thousand | -28.95 Thousand | -517.64 Thousand | 50.63 Thousand |
HESTERBIO
BAYERCROP
000550
FXBY
003040
VNO-PO